Histological Changes of Feline Mammary Carcinoma Treated by NPe6 HVJ-E PDT-Reference-Cited by-同舟云学术

Histological Changes of Feline Mammary Carcinoma Treated by NPe6 HVJ-E PDT

Published:2020-01-15 Issue:4 Volume:40 Page:403-407
ISSN:0288-6200
Container-title:Nippon Laser Igakkaishi
language:en
Short-container-title:JJSLSM

Author:

Yamashita Masamichi¹,Osaki Tomohiro¹,Sunden Yuji¹,Saito Shouko²,Inai Mizuho³,Honda Norihiro²⁴,Nishimura Takahiro²,Hazama Hisanao²,Awazu Kunio²³⁵,Kaneda Yasufumi⁶,Okamoto Yoshiharu¹

Affiliation:

1. Joint Department of Veterinary Clinical Medicine, Faculty of Agriculture, Tottori University

2. Depertment of Sustainable Energy and Environmental Engineering, School of Engineering, Osaka University

3. Graduate School of Frontier Biosciences, Osaka University

4. Institute for Academic Initiatives, Osaka University

5. Global Centre for Medical Engineering and Informatics, Osaka University

6. Depertment of Genome Biology, Graduate School of Medicine, Osaka University

Publisher

Japan Society for Laser Surgery and Medicine

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/jslsm/40/4/40_jslsm-40_0024/_pdf

Reference14 articles.

1. 1) Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, Pitot HC, Hamid O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM, Pardoll DM, Gupta A, Wigginton JM. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med. 2012; 366: 2455-2465.

2. Anticancer Immunotherapy using Inactivated Sendai Virus Particles

3. 3) Kaneda Y, Yamamoto S, Nakajima T. Development of HVJ envelope vector and its application to gene therapy. Adv Genet. 2005; 53: 307-332.

4. 4) Mima H, Yamamoto S, Ito M, Tomoshige R, Tabata Y, Tamai K, Kaneda Y. Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin-conjugated HVJ envelope vector. Mol Cancer Ther. 2006; 5: 1021-1028.

5. 5) Kurooka M, Kaneda Y. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells. Cancer Res. 2007; 67: 227-236.